Hjertner et al., "Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group
randomized phase 3 trial.," Blood, vol.
(5.) Smith A, Wisloff F, Samson D, on behalf of the UK Myeloma Forum, Nordic Myeloma Study Group
and British Committee for Standards in Haematology.
Also, in recent reports from the Nordic Myeloma Study Group
(NMSG)  and the Grupo Argentino de Tratamiento de la Leucemia Aguda (GATLA) , no differences in clinical characteristics at diagnosis were observed according to the patient's age.